|
1
|
Mignogna MD, Fedele S and Lo Russo L: The
world cancer report and the burden of oral cancer. Eur J Cancer
Prev. 13:139–142. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
van Zyl A and Bunn BK: Clinical features
of oral cancer. SADJ. 67:566–569. 2012.PubMed/NCBI
|
|
3
|
Blatt S, Kruger M, Ziebart T, Sagheb K,
Schiegnitz E, Goetze E, Al-Nawas B and Pabst AM: Biomarkers in
diagnosis and therapy of oral squamous cell carcinoma: A review of
the literature. J Craniomaxillofac Surg. 45:722–730. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhao X, Sun S, Zeng X and Cui L:
Expression profiles analysis identifies a novel three-mRNA
signature to predict overall survival in oral squamous cell
carcinoma. Am J Cancer Res. 8:450–461. 2018.PubMed/NCBI
|
|
5
|
Wilusz JE and Sharp PA: Molecular biology.
A circuitous route to noncoding RNA. Science. 340:440–441. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hentze MW and Preiss T: Circular RNAs:
Splicing's enigma variations. EMBO J. 32:923–925. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Memczak S, Jens M, Elefsinioti A, Torti F,
Krueger J, Rybak A, Maier L, Mackowiak SD, Gregersen LH, Munschauer
M, et al: Circular RNAs are a large class of animal RNAs with
regulatory potency. Nature. 495:333–338. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Du WW, Yang W, Chen Y, Wu ZK, Foster FS,
Yang Z, Li X and Yang BB: Foxo3 circular RNA promotes cardiac
senescence by modulating multiple factors associated with stress
and senescence responses. Eur Heart J. 38:1402–1412.
2017.PubMed/NCBI
|
|
9
|
Burd CE, Jeck WR, Liu Y, Sanoff HK, Wang Z
and Sharpless NE: Expression of linear and novel circular forms of
an INK4/ARF-associated non-coding RNA correlates with
atherosclerosis risk. PLoS Genet. 6:e10012332010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lukiw WJ: Circular RNA (circRNA) in
Alzheimer's disease (AD). Front Genet. 4:3072013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang J, Zhao X, Zhang J, Zheng X and Li
F: Circular RNA hsa_circ_0023404 exerts an oncogenic role in
cervical cancer through regulating miR-136/TFCP2/YAP pathway.
Biochem Biophys Res Commun. 22:428–433. 2018. View Article : Google Scholar
|
|
12
|
Li P, Yang X, Yuan W, Yang C, Zhang X, Han
J, Wang J, Deng X, Yang H, Li P, et al: CircRNA-Cdr1as exerts
anti-oncogenic functions in bladder cancer by sponging
microRNA-135a. Cell Physiol Biochem. 46:1606–1616. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liu W, Ma W, Yuan Y, Zhang Y and Sun S:
Circular RNA hsa_circRNA_103809 promotes lung cancer progression
via facilitating ZNF121-dependent MYC expression by sequestering
miR-4302. Biochem Biophys Res Commun. 500:846–851. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang L, Wei Y, Yan Y, Wang H, Yang J,
Zheng Z, Zha J, Bo P, Tang Y, Guo X, et al: CircDOCK1 suppresses
cell apoptosis via inhibition of miR196a5p by targeting BIRC3 in
OSCC. Oncol Rep. 39:951–966. 2018.PubMed/NCBI
|
|
15
|
Chen L, Zhang S, Wu J, Cui J, Zhong L,
Zeng L and Ge S: CircRNA_100290 plays a role in oral cancer by
functioning as a sponge of the miR-29 family. Oncogene.
36:4551–4561. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Galasso M, Costantino G, Pasquali L,
Minotti L, Baldassari F, Corrà F, Agnoletto C and Volinia S:
Profiling of the predicted circular RNAs in ductal in situ and
invasive breast cancer: A pilot study. Int J Genomics.
2016:45038402016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Nair AA, Niu N, Tang X, Thompson KJ, Wang
L, Kocher JP, Subramanian S and Kalari KR: Circular RNAs and their
associations with breast cancer subtypes. Oncotarget. 7:809672016.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hou P, Liu D, Shan Y, Hu S, Studeman K,
Condouris S, Wang Y, Trink A, El-Naggar AK and Tallini G: Genetic
alterations and their relationship in the phosphatidylinositol
3-kinase/Akt pathway in thyroid cancer. Clin Cancer Res.
13:11612007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li S, Ma YM, Zheng PS and Zhang P: GDF15
promotes the proliferation of cervical cancer cells by
phosphorylating AKT1 and Erk1/2 through the receptor ErbB2. J Exp
Clin Cancer Res. 37:802018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Robinson DR, Kalyana-Sundaram S, Wu YM,
Shankar S, Cao X, Ateeq B, Asangani IA, Iyer M, Maher CA, Grasso
CS, et al: Functionally recurrent rearrangements of the MAST kinase
and Notch gene families in breast cancer. Nat Med. 17:1646–1651.
2011. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang LX, Li Y and Chen GZ: Network-based
co-expression analysis for exploring the potential diagnostic
biomarkers of metastatic melanoma. PLoS One. 13:e01904472018.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zheng Y, Zhao G, Xu B, Liu C, Li C, Zhang
X and Chang X: PADI4 has genetic susceptibility to gastric
carcinoma and upregulates CXCR2, KRT14 and TNF-α expression levels.
Oncotarget. 7:62159–62176. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Na Y, Kaul SC, Ryu J, Lee JS, Ahn HM, Kaul
Z, Kalra RS, Li L, Widodo N, Yun CO and Wadhwa R: Stress chaperone
mortalin contributes to epithelial-mesenchymal transition and
cancer metastasis. Cancer Res. 76:2754–2765. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yu C, Liu SL, Qi MH, Zou X, Wu J and Zhang
J: Herbal medicine guan chang fu fang enhances 5-fluorouracil
cytotoxicity and affects drug-associated genes in human colorectal
carcinoma cells. Oncol Lett. 9:701–708. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Brunelle JK and Letai A: Control of
mitochondrial apoptosis by the Bcl-2 family. J Cell Sci.
122:437–441. 2009. View Article : Google Scholar : PubMed/NCBI
|
